Background: In low-and middle-income countries, few patients receive organized rehabilitation after stroke, yet the burden of chronic diseases such as stroke is increasing in these countries. Affordable models of effective rehabilitation could have a major impact. The ATTEND trial is evaluating a family-led caregiver delivered rehabilitation program after stroke.
As infectious diseases have been brought under increasing control, non-communicable diseases are on the rise, with stroke, in particular, increasing in incidence and subsequent burden. The majority of those with stroke live in low-and middle-income countries, and these countries have few organized stroke services. 1 In India, for example, most stroke patients do not have access to formal rehabilitation. 2 In rural areas of India, few patients get to hospital, and most do not receive appropriate secondary preventative treatment. 3 Economic drivers are clearly important as the per capita Gross Domestic Product is more than 30 times greater in countries such as the USA or Australia, as compared to India. 4 Affordable healthcare should therefore be a public health priority. The ATTEND trial of family-led rehabilitation after stroke is an international attempt to address this priority as recommended by the World Bank and World Health Organization report on Disability. 5 ATTEND is an individual subject randomized controlled trial involving the training of the patient and nominated carer in key aspects of stroke rehabilitation, with an emphasis on repeated performance in task-specific activities. The intervention was piloted, 6 and then refined with input from the steering committee and project research team in Indian.
ATTEND uses a pragmatic design, and the protocol has been published. 7 In brief, it is a randomized controlled trial across 14 sites in India. Patients are eligible if they are adults (aged 18 years or older) who were admitted to hospital with a recent (<1 month) stroke (ischemic, hemorrhagic, or undifferentiated) and had residual disability with a reasonable expectation of survival. Participants need to have had a nominated caregiver and be willing to adhere to the follow-up arrangements. After consent has been obtained from both the patient and caregiver, they were randomized through a secure web-based randomization system to either intervention or control. The intervention was started in hospital, with an aim of participants receiving it for 1 h each day until discharge, delivered by a trained stroke coordinator (usually with a physiotherapy background). Part of the intervention involved discharge planning. After discharge, the patient and carer were supported by up to five home visits by a stroke coordinator who provided them with an illustrated ATTEND manual outlining key activities. The details of the intervention have been kept confidential until the trial follow-up period has been completed to reduce the risk of contamination between intervention and control patients. Overall, the intervention was developed from new models of care emerging in India, incorporating aspects of the best evidence for stroke rehabilitation and good practice summarized in an intervention guide for the stroke coordinators. Control patients received usual care. Baseline, demographic, and initial follow-up data were collected at hospital discharge. Outcomes were collected at three months and six months post-randomization by blinded assessors employed at each site. The primary outcome is the modified Rankin Scale (mRS) at six months to reflect the lasting effects of the intervention on disability. The three-month data will be used to explore trajectories of recovery and to minimize dropouts (e.g., if a patient cannot be found at three-months, there will be another three months to try and locate the patient for the primary outcome). The main outcome was a dichotomous outcome on the mRS score of 0-2 versus 3-6, with an ordinal analysis as a key secondary outcome. Other outcomes include basic activities of daily living, quality of life, carer burden, anxiety, and depression and extended activities of daily living. Length of stay, place of residence, and return to work will also be collected, as part of a larger planned economic analysis.
The trial is funded by the National Health and Medical Research Council of Australia and recruitment commenced in January 2014 and was successfully completed (1250 participants) in early 2016. In keeping with best practice, the trial is registered and the protocol published. 7 Prior to unblinding, we present the statistical analysis plan (see supplementary material available online with this article) which helps prevent undue emphasis on data dependent analyses and reduces potential bias in future reporting. The preliminary results are expected to be announced at the World Stroke Congress in Hyderabad in October 2016.
Results from ATTEND trial have the potential to have major impact as the costs are likely to be modest, and therefore affordable to those not only in India but also in other low-and middle-income countries. If successful in the context of stroke, further work exploring similar models (a ''polypill'' of rehabilitation) would be important for other acutely disabling conditions such as hip fracture, spinal cord injury, burns, and brain injury given the burden of disease in low-and middleincome countries.
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